UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 41 filers reported holding UNUM THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $133,000 | -85.3% | 50,922 | -75.3% | 0.17% | -61.6% |
| Q1 2019 | $906,000 | -53.9% | 206,358 | -53.8% | 0.44% | +0.5% |
| Q4 2018 | $1,966,000 | -64.7% | 446,814 | -17.5% | 0.43% | -39.4% |
| Q3 2018 | $5,577,000 | -33.1% | 541,420 | -6.9% | 0.71% | -44.6% |
| Q2 2018 | $8,342,000 | -32.1% | 581,303 | -47.5% | 1.29% | +75.6% |
| Q1 2018 | $12,292,000 | – | 1,106,445 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 3,361,535 | $37,347,000 | 28.23% |
| Novo Holdings A/S | 665,181 | $31,669,000 | 3.97% |
| New Leaf Venture Partners, L.L.C. | 550,000 | $6,111,000 | 3.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,081,545 | $12,016,000 | 1.32% |
| SABBY MANAGEMENT, LLC | 1,106,445 | $12,292,000 | 0.73% |
| Monashee Investment Management LLC | 175,000 | $1,944,000 | 0.54% |
| DC Investments Management, LLC | 35,524 | $395,000 | 0.26% |
| Athanor Capital, LP | 22,300 | $248,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 225,000 | $2,499,000 | 0.07% |
| Schonfeld Strategic Advisors LLC | 73,000 | $811,000 | 0.06% |